STOCK TITAN

Procter & Gamble executive sells 2,250 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Procter & Gamble's CEO-Baby and Feminine Care, El Hak Hesham Abd, sold 2,250 shares of common stock at $168.47 per share on November 12, 2026. No Rule 10b5-1 plan is reported. After the sale, he directly held 8,968 shares. The report also lists indirect holdings of 1,542 shares through the Retirement Plan Trustee, reflecting an adjustment to PST through September 30, 2026, and 44 shares in the International Stock Ownership Plan & Pension Plan.

Insider Abd El Hak Hesham
Role CEO-Baby and Feminine Care
Sold 2,250 shs ($379K)
Type Security Shares Price Value
Sale Common Stock 2,250 $168.47 $379K
Holding Common Stock F1 -- -- --
Holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 8,967.9294 shares (Direct); Common Stock — 1,542.4822 shares (Indirect, By Retirement Plan Trustee); Common Stock — 43.95 shares (Indirect, International Stock Ownership Plan & Pension Plan)
Footnotes (1)
  1. F1. Reflects adjustment to PST through September 30, 2026.
Shares sold 2,250 shares Common stock sold on November 12, 2026
Sale price $168.47 per share Sale on November 12, 2026
Direct shares held after sale 8,968 shares As of November 12, 2026
Indirect shares held through Retirement Plan Trustee 1,542 shares As of November 12, 2026; reflects an adjustment to PST through September 30, 2026
Indirect shares held in International Stock Ownership Plan & Pension Plan 44 shares As of November 12, 2026
Rule 10b5-1 plan regulatory
"No Rule 10b5-1 plan is reported."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PG shares did the CEO-Baby and Feminine Care sell?

El Hak Hesham Abd, Procter & Gamble's CEO-Baby and Feminine Care, sold 2,250 shares of common stock at $168.47 per share on November 12, 2026. No Rule 10b5-1 plan is reported; after the sale, he directly held 8,968 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Abd El Hak Hesham

(Last)(First)(Middle)
ONE PROCTER & GAMBLE PLAZA

(Street)
CINCINNATI OHIO 45202

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PROCTER & GAMBLE Co [ PG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CEO-Baby and Feminine Care
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/12/2026S2,250D$168.478,967.9294D
Common Stock1,542.4822(1)IBy Retirement Plan Trustee
Common Stock43.95IInternational Stock Ownership Plan & Pension Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects adjustment to PST through September 30, 2026.
/s/ Jennifer Dollard-Smith, attorney-in-fact for Hesham Abd El Hak11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading